Skip to content
User

Ravenel Boykin Curry IV

Eagle Capital Management

Eagle Capital Management HealthEquity Inc stake

total: 177

Eagle Capital Management HQY trades

Total transactions:
5
New positions:
1
Sold out:
1
Added:
1
Reduced:
2
Held since:
2014 Q3
Held for:
14 quarters
Latest activity:
2018 Q1
According to 2026 Q2 report, Eagle Capital Management doesn't hold any HealthEquity Inc (HQY) shares. To date, the estimated cost basis is nearly $18.55 for "buy" trades and estimated average "sell" price is $45.51. Eagle Capital Management first purchased HQY in 2014 Q3, initially acquiring 38,700 shares. Since the initial investment in HealthEquity Inc (HQY), Eagle Capital Management has made 4 more transactions.

When did Eagle Capital Management sell HealthEquity Inc (HQY)?

Eagle Capital Management sold off the entire HealthEquity Inc (HQY) position in 2018 Q1.

When did Eagle Capital Management buy HealthEquity Inc (HQY)?

Eagle Capital Management first invested in HealthEquity Inc (HQY) in 2014 Q3 at the reported quarter-end price of $18.32 per share.

What's the cost basis of Eagle Capital Management's HQY stake?

The estimated cost basis for HealthEquity Inc (HQY) stake is around $18.55 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$18.55
Weighted AVG sell price:
$45.51

Eagle Capital Management's historical trades in HealthEquity Inc

5 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2018 Q1
0.00%
$46.67
-100% (-34,500)
2017 Q1
0.01%
$42.46
-1.43% (-500)
2016 Q3
0.01%
$37.86
-12.50% (-5,000)
2014 Q4
0.00%
$25.45
+3.36% (+1,300)
2014 Q3
0.00%
$18.32
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.